Sigma-Aldrich Earnings: Here’s Why Investors are Buying Shares Now
Sigma-Aldrich Corporation (NASDAQ:SIAL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 2.03%.
Sigma-Aldrich Corporation Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 4.04% to $1.03 in the quarter versus EPS of $0.99 in the year-earlier quarter.
Revenue: Rose 1.5% to $675 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Sigma-Aldrich Corporation reported adjusted EPS income of $1.03 per share. By that measure, the company beat the mean analyst estimate of $1. It beat the average revenue estimate of $672.82 million.
Quoting Management: Commenting on first quarter 2013 performance, President and CEO Rakesh Sachdev said, “We reported record quarterly sales and diluted EPS of $675 million and $1.01, respectively. Our overall end markets remain steady with improving pharma trends offset by slower academic spending. We remain on track to achieve our 2013 full-year organic sales growth and adjusted EPS guidance.”
Key Stats (on next page)…
Revenue increased 3.05% from $655 million in the previous quarter. EPS increased 7.29% from $0.96 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $1.04 and has not changed. For the current year, the average estimate has moved down from a profit of $4.15 to a profit of $4.13 over the last ninety days.